Biohacking Market to reach USD 85.78 billion by 2032 and grow at a CAGR of 16.86%
The biohacking market is rapidly expanding due to the development of biotechnology, wearable health devices, nootropics, and genetic engineering. Biohacking has also become a related term for human augmentation. The activity involves self-experimentation techniques that contribute to cognitive function improvements, changes in physical performance, and longevity. The trend is being mainstreamed through increasing funding from tech entrepreneurs, venture capitalists, and healthcare innovators.